For the quarter ending 2026-03-31, PRCT made $83,132K in revenue. -$31,694K in net income. Net profit margin of -38.12%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 83,132 | 76,383 | 83,327 | 79,182 |
| Cost of sales | 29,185 | 30,070 | 29,321 | 27,436 |
| Gross profit | 53,947 | 46,313 | 54,006 | 51,746 |
| Research and development | 21,465 | 19,056 | 18,187 | 17,632 |
| Selling, general and administrative | 65,088 | 58,297 | 59,011 | 56,303 |
| Total operating expenses | 86,553 | 77,353 | 77,198 | 73,935 |
| Loss from operations | -32,606 | -31,040 | -23,192 | -22,189 |
| Interest expense | 818 | 895 | 919 | 895 |
| Interest and other income, net | 1,743 | 2,279 | 2,700 | 3,506 |
| Loss before provision for income taxes | -31,681 | -29,798* | - | - |
| Provision for income taxes | -43 | 48* | - | - |
| Net loss | -31,638 | -29,846 | -21,411 | -19,578 |
| Foreign currency translation adjustment | -56 | -5 | 186 | -367 |
| Unrealized gain on cash equivalents | - | 0 | 0 | 0 |
| Comprehensive loss | -31,694 | -29,851 | -21,225 | -19,945 |
| Basic EPS | -0.56 | -0.532 | -0.38 | -0.35 |
| Diluted EPS | -0.56 | -0.532 | -0.38 | -0.35 |
| Basic Average Shares | 56,511,000 | 56,087,000 | 55,727,000 | 55,445,000 |
| Diluted Average Shares | 56,511,000 | 56,087,000 | 55,727,000 | 55,445,000 |
PROCEPT BioRobotics Corp (PRCT)
PROCEPT BioRobotics Corp (PRCT)